Related Experiment Videos
Nerve growth factor induces gene expression of the prion protein and beta-amyloid protein precursor in the developing
M P McKinley1, F M Longo, J S Valletta
1Department of Neurology, University of California, San Francisco 94143.
Progress in Brain Research
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Targeting Endogenous Mechanisms of Brain Resilience for the Treatment and Prevention of Alzheimer's Disease.
The journal of prevention of Alzheimer's disease·2023
Non-Amyloid Approaches to Disease Modification for Alzheimer's Disease: An EU/US CTAD Task Force Report.
The journal of prevention of Alzheimer's disease·2020
Neuroscience and biomarkers of sleep in preterm and term infants: From state organization to clinical translation.
Progress in brain research·2026
Restless legs syndrome and periodic limb movement disorders.
Progress in brain research·2026
Cognitive function in central disorders of hypersomnolence.
Progress in brain research·2026
Future horizons: Toward an integrated neuroscience of sleep.
Progress in brain research·2026
Neural correlates of insomnia and hyperarousal.
Progress in brain research·2026
REM sleep behavior disorder and synucleinopathies.
Progress in brain research·2026
Synergistic effects of cerebrovascular reactivity and gray matter volume on executive function in aging.
Journal of Alzheimer's disease : JAD·2026
Acute Neurological Manifestations in COVID-19 Are Associated With Complement Activation and Glia-Promoted Neuroinflammation.
Journal of medical virology·2026
Identifying poor responders to repetitive transcranial magnetic stimulation using structural brain networks.
Progress in neuro-psychopharmacology & biological psychiatry·2026
14-3-3γ Protects Against Postoperative Cognitive Dysfunction by Regulating Tau Thr205 Phosphorylation and Synaptic Integrity.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
A BSCB-Penetrating Nanoplatform for Enhanced Luteolin Delivery in PRMT2-Targeted Epigenetic Therapy of Spinal Cord Injury.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026